This observation finds resonance with certain Asian studies, which have indicated that the use of rituximab and G‐CSF in combination with CHOP‐type chemotherapy is a contributing factor to interstitial pneumonitis.19, 20. The gene discussed is CSF3; the disease is Interstitial pneumonitis.